IKKε-IN-1CAS# 1292310-49-6 |
2D Structure
- Celastrol
Catalog No.:BCN5986
CAS No.:34157-83-0
- BMS-345541
Catalog No.:BCC1423
CAS No.:547757-23-3
- Bay 65-1942 free base
Catalog No.:BCC1408
CAS No.:600734-02-9
- Bay 65-1942 HCl salt
Catalog No.:BCC1409
CAS No.:600734-06-3
- Bay 65-1942 R form
Catalog No.:BCC1410
CAS No.:758683-21-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1292310-49-6 | SDF | Download SDF |
PubChem ID | 51049969 | Appearance | Powder |
Formula | C26H27N5O3 | M.Wt | 457.52 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 21.5 mg/mL (46.99 mM; Need ultrasonic and warming) | ||
Chemical Name | 5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile | ||
SMILES | C1COCCC1OC2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5)C#N | ||
Standard InChIKey | BWABTWGSXHTHCG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
IKKε-IN-1 Dilution Calculator
IKKε-IN-1 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1857 mL | 10.9285 mL | 21.857 mL | 43.7139 mL | 54.6424 mL |
5 mM | 0.4371 mL | 2.1857 mL | 4.3714 mL | 8.7428 mL | 10.9285 mL |
10 mM | 0.2186 mL | 1.0928 mL | 2.1857 mL | 4.3714 mL | 5.4642 mL |
50 mM | 0.0437 mL | 0.2186 mL | 0.4371 mL | 0.8743 mL | 1.0928 mL |
100 mM | 0.0219 mL | 0.1093 mL | 0.2186 mL | 0.4371 mL | 0.5464 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
TBK1/IKKε-IN-2 is a dual TBK1 and IKKε inhibitor.
In Vitro:TBK1/IKKε-IN-2 (Cmpound #1) inhibits TBK1 biochemical function in Ulight kinase assay at 5 and 250 μM ATP concentration with IC50s of 0.6 and 2.6 nM, rsespectively. TBK1/IKKε-IN-2 inhibits IKKε biochemical function in Ulight kinase assay at 10 μM ATP with an IC50 of 3.9 nM. The IC50 of TBK1/IKKε-IN-2 in the Panc 02.13 proliferation assay is 5 μM[1].
References:
[1]. Muvaffak A, et al. Evaluating TBK1 as a therapeutic target in cancers with activated IRF3. Mol Cancer Res. 2014 Jul;12(7):1055-66.
- 15-Dihydroepioxylubimin
Catalog No.:BCN4800
CAS No.:129214-59-1
- (2S,3S)-(-)-Glucodistylin
Catalog No.:BCN6156
CAS No.:129212-92-6
- Iberiotoxin
Catalog No.:BCC6932
CAS No.:129203-60-7
- Biotin-HPDP
Catalog No.:BCC3583
CAS No.:129179-83-5
- Gancaonin M
Catalog No.:BCN4757
CAS No.:129145-51-3
- 2-(2,2-Dimethyl-1,3-dioxolan-4-yl)propane-1,2-diol
Catalog No.:BCC8475
CAS No.:129141-48-6
- CGRP 8-37 (rat)
Catalog No.:BCC5717
CAS No.:129121-73-9
- ENMD-2076 L-(+)-Tartaric acid
Catalog No.:BCC2185
CAS No.:1291074-87-7
- Evodosin A
Catalog No.:BCN7322
CAS No.:1291053-38-7
- Rivastigmine Tartrate
Catalog No.:BCC3851
CAS No.:129101-54-8
- Buclizine HCl
Catalog No.:BCC4516
CAS No.:129-74-8
- SP 600125
Catalog No.:BCC2474
CAS No.:129-56-6
- Hoechst 33258 analog 6
Catalog No.:BCC1628
CAS No.:129244-66-2
- Perospirone hydrochloride
Catalog No.:BCC9118
CAS No.:129273-38-7
- Pierreione B
Catalog No.:BCN6855
CAS No.:1292766-21-2
- Boscialin
Catalog No.:BCN7323
CAS No.:129277-03-8
- PF-2545920
Catalog No.:BCC2279
CAS No.:1292799-56-4
- Semilicoisoflavone B
Catalog No.:BCN2931
CAS No.:129280-33-7
- Isoangustone A
Catalog No.:BCN6819
CAS No.:129280-34-8
- Licorisoflavan A
Catalog No.:BCN6662
CAS No.:129314-37-0
- Alendronate sodium
Catalog No.:BCC3719
CAS No.:129318-43-0
- O-Geranylconiferyl alcohol
Catalog No.:BCN4747
CAS No.:129350-09-0
- 11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
Catalog No.:BCC8430
CAS No.:129385-59-7
- Physcion 8-O-rutinoside
Catalog No.:BCN7324
CAS No.:129393-21-1